KHA-CARI指南：腹膜炎的治疗与预防 - Suppr

Suppr

超能文献

KHA-CARI Guideline: peritonitis treatment and prophylaxis.

作者信息

Walker Amanda, Bannister Kym, George Charles, Mudge David, Yehia Maha, Lonergan Maureen, Chow Josephine

机构信息

Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Australia.

出版信息

Nephrology (Carlton). 2014 Feb;19(2):69-71. doi: 10.1111/nep.12152.

DOI:10.1111/nep.12152

PMID:23944845

Abstract

摘要

相似文献

KHA-CARI Guideline: peritonitis treatment and prophylaxis.KHA-CARI指南：腹膜炎的治疗与预防

Nephrology (Carlton). 2014 Feb;19(2):69-71. doi: 10.1111/nep.12152.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: the influence of peritoneal dialysis systems and solutions on the incidence of peritonitis and catheter-related infections.《社区获得性感染指南》。腹膜炎治疗与预防的证据：腹膜透析系统及溶液对腹膜炎和导管相关感染发生率的影响

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S41-4. doi: 10.1111/j.1440-1797.2004.00296.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylactic antibiotics for insertion of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入术的预防性抗生素应用

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S72-5. doi: 10.1111/j.1440-1797.2004.00303.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: peritoneal dialysis-associated peritonitis in children.CARI指南。腹膜炎治疗与预防的证据：儿童腹膜透析相关腹膜炎

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S45-51. doi: 10.1111/j.1440-1797.2004.00297.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: type of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管类型

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S59-64. doi: 10.1111/j.1440-1797.2004.00301.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: technique of insertion of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入技术。

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S65-71. doi: 10.1111/j.1440-1797.2004.00302.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: indications for recommencement of peritoneal dialysis after treatment for peritonitis.《社区获得性肾衰竭指南》。腹膜炎治疗与预防的证据：腹膜炎治疗后重新开始腹膜透析的指征。

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S52-3. doi: 10.1111/j.1440-1797.2004.00298.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: timing of commencement of dialysis after peritoneal dialysis catheter insertion.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入术后开始透析的时机。

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S76-7. doi: 10.1111/j.1440-1797.2004.00304.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: peritoneal dialysis catheter-related infection: exit site and tunnel.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管相关感染：出口部位与隧道。

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S82-5. doi: 10.1111/j.1440-1797.2004.00294.x.

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin.CARI指南。腹膜炎治疗与预防的证据：使用莫匹罗星预防出口部位/隧道感染。

Nephrology (Carlton). 2004 Oct;9 Suppl 3:S86-90. doi: 10.1111/j.1440-1797.2004.00295.x.

引用本文的文献

Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study.腹膜透析人群中腹膜炎与心血管死亡率随时间的关联：一项澳大利亚和新西兰透析与移植登记研究

Kidney Int Rep. 2022 Aug 24;7(11):2388-2396. doi: 10.1016/j.ekir.2022.08.008. eCollection 2022 Nov.

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.用于预防腹膜透析患者腹膜炎的抗菌药物。

Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.

Changes in the worldwide epidemiology of peritoneal dialysis.腹膜透析的全球流行病学变化。

Nat Rev Nephrol. 2017 Feb;13(2):90-103. doi: 10.1038/nrneph.2016.181. Epub 2016 Dec 28.

The Current State of Peritoneal Dialysis.腹膜透析的现状

J Am Soc Nephrol. 2016 Nov;27(11):3238-3252. doi: 10.1681/ASN.2016010112. Epub 2016 Jun 23.

Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry Analysis.与腹膜炎风险相关的特定中心因素——一项多中心注册研究分析

Perit Dial Int. 2016;36(5):509-18. doi: 10.3747/pdi.2015.00146. Epub 2016 Jan 13.

Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis.辅助性组织型纤溶酶原激活剂（tPA）和脱氧核糖核酸酶（DNase）用于腹膜透析相关性腹膜炎的临床前评估。

PLoS One. 2015 Mar 5;10(3):e0119238. doi: 10.1371/journal.pone.0119238. eCollection 2015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验